But right now, we dont have the data to confirm this is definitively the case, and anyone selling you certainty on this point is misleading you (or doesnt know what theyre talking about)
One of MOTS-C's downstream effects is increasing intracellular NAD+ utilization the mitochondria are running harder, so they're consuming more of the NAD+ pool
For more on weight-loss drugs, see our blog series.
The largest US peptide manufacturers are Contract Development and Manufacturing Organizations (CDMOs) such as Bachem, AmbioPharm, CordenPharma, and PolyPeptide Group, which produce peptide APIs (Active Pharmaceutical Ingredients) at pharmaceutical scale
By Olivia Lockhart, Peptide Researcher & Analyst, 10+ years
Then, patients move to monthly maintenance doses to keep B12 levels steady over time